TUESDAY, June 17, 2025 (HealthDay News) — A diet meant to lower blood pressure also can be effective in treating type 2 diabetes after a few tweaks, a new clinical trial indicates. The DASH (Dietary Approaches to Stop Hypertension) diet effectively treated high blood pressure among type 2 diabetics, researchersContinue Reading
MONDAY, June 9, 2025 (HealthDay News) — Prompt treatment with a drug combo can effectively manage chronic kidney disease in people with type 2 diabetes, a new clinical trial shows. Patients prescribed the combination of finerenone and empagliflozin experienced a 52% decrease in their urinary albumin-to-creatinine ratio, researchers report inContinue Reading
FRIDAY, June 6, 2025 (HealthDay News) — A repurposed diabetes drug can be an effective tool against fatty liver disease, a new clinical trial has found. Dapagliflozin helped people reduce fat levels in their liver and avoid liver scarring that comes with the condition, which doctors call metabolic dysfunction-associated steatohepatitis,Continue Reading
FRIDAY, May 30, 2025 (HealthDay News) — Twice as many Americans now face the increased risk of death that comes from having both high blood pressure and type 2 diabetes, a new study reports. About 12% of the U.S. population had high blood pressure and type 2 diabetes at theContinue Reading
THURSDAY, May 29, 2025 (HealthDay News) — Heart disease, strokes and diabetes contribute to many dementia cases in the United States, but the risk is not equal everywhere, a new study says. Overall, more than a third (37%) of U.S. dementia cases are linked to eight conditions: diabetes, heart failure,Continue Reading
WEDNESDAY, May 28, 2025 (HealthDay News) — Preschoolers who don’t naturally lose weight are more likely to develop full-fledged childhood obesity by age 9, a new study says. Most kids tend to see their body-mass index (BMI) decline between ages 1 and 6, before starting to slowly gain weight asContinue Reading
WEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic and Zepbound can help reduce a woman’s risk for as many as 14 cancers associated with obesity, a new study says. People taking a GLP-1 drug had a 7% lower risk of developing an obesity-related cancerContinue Reading
WEDNESDAY, May 21, 2025 (HealthDay News) — Battling chronic disease really takes it out of a person, leaving them vulnerable to depression. And people with multiple long-term health problems are even more likely to fall prey to depression, a new study says. Some combinations of illnesses can more than doubleContinue Reading
FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases. The deal could be worth up to $2.2 billion for Septerna. This includes more than $200 million inContinue Reading
FRIDAY, May 16, 2025 (HealthDay News) — People who develop type 1 diabetes in adulthood have a higher risk of heart disease and death, a new study says. However, these patients can improve their odds through healthy lifestyle habits, researchers reported May 14 in the European Heart Journal. “We showContinue Reading